Member Labs

Weapons Technology Repurposed for Peaceful Use in Medical Prosthetics

iStock 000017553841Small

A group of groundbreaking American and Russian scientists, led by Dr. Terry Lowe, chief scientist at Manhattan Scientifics, are taking Cold War weapons technology and repurposing it for peaceful use in medical prosthetics and dental implants. Manhattan Scientifics holds an exclusive license for U.S. rights from Los Alamos National Laboratory (LANL) in New Mexico.

Nanotitanium, a new FDA-approved super-metal that is stronger than conventional metal alloys, integrates more quickly with human bone—and is expected to be more reliable and longer lasting, and provide faster post-surgery healing. Nanotitanium is the product of a collaboration of U.S. scientists at LANL and Russian weapons technology scientists who teamed together under direction from the U.S. Global Initiative for Proliferation Prevention at the U.S. Department of Energy.

The first FDA-approved dental implant made with nanotitanium was installed in the mouth of Dr. Terry Lowe, the scientist who helped develop it, on October 14, 2010. The implant is manufactured and distributed by Basic Dental, Inc., of Albuquerque, under a limited license from Manhattan Scientifics, who also issued a broader exclusive license to a major Fortune/1000 U.S. NYSE metals manufacturing company to cover other medical and non-medical applications for the new class of super strong, super light metals.

According to CEO Manny Tsoupanarias, "The dental implant market is characterized as a large, underpenetrated global opportunity. In recent years, increasing aging population coupled with rising awareness for oral health, high aesthetics and improved dental treatments have boosted the growth of this segment to double digits thanks to the rising edentulous population worldwide."

"We’re living longer, and we need new parts," said Marvin Maslow, Manhattan Scientific founder and director of public and investor relations. "Manhattan Scientifics is in the new parts business, and it is a big business. The current worldwide dental implant market is $3.5 billion this year, according to a study prepared by Kalorama Information. The potential for our new product beyond the dental market is significant. ’Dental’ application is only the tip of the iceberg. The global market for minimally invasive prosthetic devices is presently at $23 billion. Our goal by introducing nanotitanium is to trigger the beginning of a new era for the prosthetics and medical device industry."

LANL licensed the technology to Metallicum, Inc., a spin-out with Dr. Terry Lowe as CEO. Dr. Lowe was granted an entrepreneurial leave of absence from LANL in an effort to commercialize the technology. Manhattan Scientifics acquired Metallicum in 2009.

Since its inception, Manhattan Scientifics has been a technology developer that nurtures financially promising technologies with potential global commercial applications. Manhattan Scientifics has enjoyed a "special informal relationship" and a lengthy successful history in tech transfer with LANL and Sandia National Laboratories.

Member Labs